Nel ASA: A $372 Million Market Cap Keeps Institutional Money on the Sidelines
Published on 07/25/2026 at 11:31 | Redaktion boerse-global.de
The math is brutally simple for Nel ASA: with a market capitalisation of roughly €372 million, the Norwegian hydrogen company is simply too small to register on the radar of most institutional investors. The consequence is a stock dominated by short-term traders, with the long-term capital that could provide stability almost entirely absent.
That structural problem compounds a fundamental one. Nel's second-quarter numbers, released in late August, tell a story of explosive order growth running headlong into deepening losses. The order intake surged to 230 million Norwegian kroner in the April-to-June period, a 171 percent jump from the previous quarter and a 224 percent leap year-on-year. Yet the revenue from customer contracts actually fell, dropping 12 percent to 153 million kroner from 174 million a year earlier.
The gap between what customers are ordering and what Nel is billing is widening, and the cost side tells an even starker tale. EBITDA swung to a loss of 155 million kroner, compared with a negative 86 million kroner in the same quarter of 2025. A one-off item accounted for a significant chunk of that deterioration: a 70 million kroner settlement with Iwatani Corporation of America, resolving a legal dispute that had been hanging over the company.
The cash position offers some breathing room, though the trend is concerning. Nel ended the quarter with 1.328 billion kroner in the bank, down from 1.928 billion a year earlier. That burn rate underscores how much capital the current operations are consuming, even as the order backlog swells to 1.213 billion kroner — a pipeline that gives the company time, but not unlimited time, to convert orders into cash flow.
Should investors sell immediately? Or is it worth buying Nel ASA?
Adding to the uncertainty, CEO HĂĄkon Volldal announced his departure during the second-quarter conference call, saying he was leaving to pursue a new professional challenge. Volldal, who took the helm in July 2022, will remain for up to six months while the board searches for a successor. The company insists its strategic direction is unchanged, but a leadership transition at a moment when the business is burning cash and struggling to monetise its order book adds a layer of risk that investors are already pricing in.
The stock closed Friday at €0.1968, down 2.09 percent on the day but still showing a modest 2.18 percent gain for the week. The broader picture is less encouraging: the share has lost 7.17 percent over the past 30 days and sits roughly 46 percent below its 52-week high of €0.3655, reached on May 25. Technical indicators reinforce the bearish mood — the current price is 8.34 percent below the 200-day moving average of €0.2147, a classic warning signal for a sustained downtrend. The relative strength index stands at 36.5, indicating selling pressure without yet reaching oversold territory.
The 30-day annualised volatility of nearly 42 percent reflects how sensitive hydrogen stocks remain to shifting interest rate expectations and global economic signals. For Nel, the challenge is compounded by the fact that its new pressurised alkaline electrolyser platform — touted as a key growth driver — has yet to prove its commercial viability.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
For traders, the stock may offer short-term opportunities around the €0.18 support level, but a convincing entry point for longer-term investors would require a confirmed breakout above €0.25. With the current news flow pointing in the opposite direction, Nel remains a vehicle for speculators rather than a home for patient capital. The next major test comes on October 21, when the company reports third-quarter results — the first real chance to see whether the order boom is finally translating into revenue, or whether the gap between promise and delivery is still widening.
Ad
Nel ASA Stock: New Analysis - 25 July
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
